{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:45:10Z","timestamp":1767008710172,"version":"3.46.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":248,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We describe a case of a previously well 76-year-old woman who presented with 9 months of a generalised pruritic rash alongside fatigue, weight-loss and a symmetrical weakness of the legs.<\/jats:p>","DOI":"10.1002\/ski2.366","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T06:40:45Z","timestamp":1710139245000},"source":"Crossref","is-referenced-by-count":1,"title":["Anti-TIF-1\u03b3 Dermatomyositis: Erythematous Eruption with Weakness and Normal Creatine Kinase"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3592-4373","authenticated-orcid":false,"given":"Lucy","family":"Mackie","sequence":"first","affiliation":[{"name":"Department of Medicine, Croydon University Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilukshi","family":"Wijesuriya","sequence":"additional","affiliation":[{"name":"Department of Pathology, St George\u2019s Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Iyer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Croydon University Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"issue":"1","key":"2025112605220785900_ski2366-bib-0001","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"2","key":"2025112605220785900_ski2366-bib-0002","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2025112605220785900_ski2366-bib-0003","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/bjd.17098","article-title":"Autoantibody to transcriptional intermediary factor-1\u03b2 as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy","volume":"180","author":"Ueda-Hayakawa","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"2025112605220785900_ski2366-bib-0004","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2025112605220785900_ski2366-bib-0005","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071925","article-title":"Clinical characteristics of anti-TIF-1\u03b3 antibody-positive dermatomyositis associated with malignancy","volume":"11","author":"Harada","year":"2022","journal-title":"J Clin Med"},{"issue":"12","key":"2025112605220785900_ski2366-bib-0006","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-014-0465-0","article-title":"Amyopathic dermatomyositis: definitions, diagnosis, and management","volume":"16","author":"Bailey","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"2025112605220785900_ski2366-bib-0007","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/bjd.17536","article-title":"The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria","volume":"180","author":"Concha","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"2025112605220785900_ski2366-bib-0008","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232260","article-title":"A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level","volume":"13","author":"Kwan","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"12","key":"2025112605220785900_ski2366-bib-0009","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2025112605220785900_ski2366-bib-0010","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","article-title":"The role of high-dose immune globulin intravenous in the treatment of dermatomyositis","volume":"6","author":"Dalakas","year":"2006","journal-title":"Int Immunopharm"},{"issue":"1","key":"2025112605220785900_ski2366-bib-0011","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1346-8138.15128","article-title":"Anti-transcriptional intermediary factor 1-\u03b3 antibody as a biomarker in patients with dermatomyositis","volume":"47","author":"Shimizu","year":"2020","journal-title":"J Dermatol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/3\/ski2.366\/60660757\/skinhd_4_3_e366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/3\/ski2.366\/60660757\/skinhd_4_3_e366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:22:16Z","timestamp":1764152536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.366\/7896810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,11]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.366","relation":{},"ISSN":["2690-442X"],"issn-type":[{"type":"electronic","value":"2690-442X"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,11]]},"article-number":"ski2.366"}}